Nobiletin as a chemopreventive natural product against cancer, a comprehensive review

References

• Aoki, K., A. Yokosuka, Y. Mimaki, K. Fukunaga, and T. Yamakuni. 2013. Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells. Biological & Pharmaceutical Bulletin 36 (4):540–7. doi: 10.1248/bpb.b12-00824.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh, M., A. Zarrabi, S. Saberifar, F. Hashemi, K. Hushmandi, F. Hashemi, E. R. Moghadam, R. Mohammadinejad, M. Najafi, and M. Garg. 2020. Nobiletin in cancer therapy: How this plant derived-natural compound targets various oncogene and onco-suppressor pathways. Biomedicines 8 (5):110. doi: 10.3390/biomedicines8050110.
   PubMed Web of Science ®Google Scholar
• Atanasov, G., S. B. Zotchev, V. M. Dirsch, C. T. Supuran, and the International Natural Product Sciences Taskforce. 2021. Natural products in drug discovery: Advances and opportunities. Nature Reviews Drug Discovery 20 (3):200–16. doi: 10.1038/s41573-020-00114-z.
   PubMed Web of Science ®Google Scholar
• Baek, S. H., S. M. Kim, D. Nam, J. H. Lee, K. S. Ahn, S. H. Choi, S. H. Kim, B. S. Shim, I. M. Chang, and K. S. Ahn. 2012. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9. Pharmaceutical Biology 50 (10):1210–8. doi: 10.3109/13880209.2012.664151.
   PubMed Web of Science ®Google Scholar
• Borah, N., S. Gunawardana, H. Torres, S. McDonnell, and S. Van Slambrouck. 2017. 5,6,7,3’,4’,5’-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle. International Journal of Oncology 51 (6):1685–93. doi: 10.3892/ijo.2017.4157.
   PubMed Web of Science ®Google Scholar
• Brew, K., D. Dinakarpandian, and H. Nagase. 2000. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochimica Et Biophysica Acta (Bba)—Protein Structure and Molecular Enzymology 1477 (1–2):267–83. doi: 10.1016/S0167-4838(99)00279-4.
   PubMed Web of Science ®Google Scholar
• Candas, D., M. Fan, D. Nantajit, A. T. Vaughan, J. S. Murley, G. E. Woloschak, D. J. Grdina, and J. J. Li. 2013. CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. Journal of Molecular Cell Biology 5 (3):166–75. doi: 10.1093/jmcb/mjs062.
   PubMed Web of Science ®Google Scholar
• Catanzaro, E., G. Greco, L. Potenza, C. Calcabrini, and C. Fimognari. 2018. Natural products to fight cancer: A focus on Juglans regia. Toxins 10 (11):469. doi: 10.3390/toxins10110
   PubMed Web of Science ®Google Scholar
• Akao, Y., T. Itoh, K. Ohguchi, M. Iinuma, and Y. Nozawa. 2008. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorganic & Medicinal Chemistry 16 (6):2803–10. doi: 10.1016/j.bmc.2008.01.058.
   PubMed Web of Science ®Google Scholar
• Chen, J., A. Creed, A. Y. Chen, H. Huang, Z. Li, G. O. Rankin, X. Ye, G. Xu, and Y. C. Chen. 2014b. Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells. BMC Pharmacology & Toxicology 15:59. doi: 10.1186/2050-6511-15-59.
   PubMed Web of Science ®Google Scholar
• Chen, J., A. Y. Chen, H. Huang, X. Ye, W. D. Rollyson, H. E. Perry, K. C. Brown, Y. Rojanasakul, G. O. Rankin, P. Dasgupta, et al. 2015. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway. International Journal of Oncology 46 (6):2629–38. doi: 10.3892/ijo.2015.2946.
   PubMed Web of Science ®Google Scholar
• Chen, P. Y., Y. T. Chen, W. Y. Gao, M. J. Wu, and J. H. Yen. 2018. Nobiletin down-regulates c-KIT gene expression and exerts antileukemic effects on human acute myeloid leukemia cells. Journal of Agricultural and Food Chemistry 66 (51):13423–34. doi: 10.1021/acs.jafc.8b05680.
   PubMed Web of Science ®Google Scholar
• Chiang, S. Y., S. M. Kim, C. Kim, J. Y. Um, K. R. Park, S. W. Kim, S. G. Lee, H. J. Jang, D. Nam, K. S. Ahn, et al. 2012. Antiproliferative effects of Dangyuja (Citrus grandis Osbeck) leaves through suppression of constitutive signal transducer and activator of transcription 3 activation in human prostate carcinoma DU145 cells. Journal of Medicinal Food 15 (2):152–60. doi: 10.1089/jmf.2011.1671.
   PubMed Web of Science ®Google Scholar
• Cheng, H. L., M. J. Hsieh, J. S. Yang, C. W. Lin, K. H. Lue, K. H. Lu, and S. F. Yang. 2016. Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget 7 (23):35208–23. doi: 10.18632/oncotarget.9106.
   PubMedGoogle Scholar
• Chen, C., M. Ono, M. Takeshima, and S. Nakano. 2014a. Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. Anticancer Research 34 (4):1785–92. PMID: 24692711
   PubMed Web of Science ®Google Scholar
• Chien, S. Y., M. J. Hsieh, C. J. Chen, S. F. Yang, and M. K. Chen. 2015. Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2. Expert Opinion on Therapeutic Targets 19 (3):307–20. doi: 10.1517/14728222.2014.992875.
   PubMed Web of Science ®Google Scholar
• Chu, L.-Y., D. P. Ramakrishnan, and R. L. Silverstein. 2013. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells. Blood 122 (10):1822–32. doi: 10.1182/blood-2013-01-482315.
   PubMed Web of Science ®Google Scholar
• Cincin, Z. B., B. Kiran, Y. Baran, and B. Cakmakoglu. 2018. Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 103:336–45. doi: 10.1016/j.biopha.2018.04.020.
   PubMed Web of Science ®Google Scholar
• Da, C., Y. Liu, Y. Zhan, K. Liu, and R. Wang. 2016. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway . Oncology Reports 35 (5):2767–74. doi: 10.3892/or.2016.4661.
   PubMed Web of Science ®Google Scholar
• de Oliveira, J. M. P. F., C. Santos, and E. Fernandes. 2020. Therapeutic potential of hesperidin and its aglycone hesperetin: Cell cycle regulation and apoptosis induction in cancer models. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology 73:152887. doi: 10.1016/j.phymed.2019.152887.
   PubMed Web of Science ®Google Scholar
• Denaro, M., A. Smeriglio, J. Xiao, L. Cornara, B. Burlando, and D. Trombetta. 2020. New insights into citrus genus: From ancient fruits to new hybrids. Food Frontiers 1 (3):305–28. doi: 10.1002/fft2.38.
   Google Scholar
• Deveci Ozkan, A., S. Kaleli, H. I. Onen, M. Sarihan, G. Guney Eskiler, A. Kalayci Yigin, and M. Akdogan. 2020. Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells. Immunopharmacology and Immunotoxicology 42 (2):93–100. doi: 10.1080/08923973.2020.1725040.
   PubMed Web of Science ®Google Scholar
• Elmore, S. 2007. Apoptosis: A review of programmed cell death. Toxicologic Pathology 35 (4):495–516. doi: 10.1080/01926230701320337.
   PubMed Web of Science ®Google Scholar
• Fan, Y., R. Mao, and J. Yang. 2013. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein & Cell 4 (3):176–85. doi: 10.1007/s13238-013-2084-3.
   PubMed Web of Science ®Google Scholar
• Feng, S. L., H. F. Zhou, D. Y. Wu, D. C. Zheng, B. Qu, R. M. Liu, C. Zhang, Z. Li, Y. Xie, and H. B. Luo. 2020. Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: Total synthesis and discovery of potent MDR reversal agents. Acta Pharmaceutica Sinica. B 10 (2):327–43. doi: 10.1016/j.apsb.2019.07.007.
   PubMed Web of Science ®Google Scholar
• Ferrara, N. 2004. Vascular endothelial growth factor as a target for anticancer therapy. The Oncologist 9 (S1):2–10. doi: 10.1634/theoncologist.9-suppl_1-2.
   PubMed Web of Science ®Google Scholar
• Fischer, N., E. J. Seo, and T. Efferth. 2018. Prevention from radiation damage by natural products. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology 47:192–200. doi: 10.1016/j.phymed.2017.11.005.
   PubMed Web of Science ®Google Scholar
• Fleisher, B., J. Unum, J. Shao, and G. An. 2015. Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: A new mechanism of beverage-drug interaction. Journal of Pharmaceutical Sciences. 104 (1):266–75. doi: 10.1002/jps.24289.
   PubMed Web of Science ®Google Scholar
• Floor, S. L., J. E. Dumont, C. Maenhaut, and E. Raspe. 2012. Hallmarks of cancer: Of all cancer cells, all the time? Trends in Molecular Medicine 18 (9):509–15. doi: 10.1016/j.molmed.2012.06.005.
   PubMed Web of Science ®Google Scholar
• Forsythe, J. A., B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, and G. L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 16 (9):4604–13. doi: 10.1128/MCB.16.9.4604.
   PubMed Web of Science ®Google Scholar
• Galluzzi, L., A. Lopez-Soto, S. Kumar, and G. Kroemer. 2016. Caspases connect cell-death signaling to organismal homeostasis. Immunity 44 (2):221–31. doi: 10.1016/j.immuni.2016.01.020.
   PubMed Web of Science ®Google Scholar
• Gao, X. J., J. W. Liu, Q. G. Zhang, J. J. Zhang, H. T. Xu, and H. J. Liu. 2015. Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b. Die Pharmazie 70 (4):256–62. doi: 10.1691/ph.2015.4826.
   PubMed Web of Science ®Google Scholar
• Gao, Z., W. Gao, S. L. Zeng, P. Li, and E. H. Liu. 2018. Chemical structures, bioactivities and molecular mechanisms of citrus polymethoxyflavones. Journal of Functional Foods 40:498–509. doi: 10.1016/j.jff.2017.11.036.
   Web of Science ®Google Scholar
• George, V. C., G. Dellaire, and H. P. V. Rupasinghe. 2017. Plant flavonoids in cancer chemoprevention: Role in genome stability. The Journal of Nutritional Biochemistry 45:1–14. doi: 10.1016/j.jnutbio.2016.11.007.
   PubMed Web of Science ®Google Scholar
• Ghorbani, A., M. Nazari, M. Jeddi-Tehrani, and H. Zand. 2012. The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: Involvement of PPARγ-dependent mechanism . European Journal of Nutrition 51 (1):39–46. doi: 10.1007/s00394-011-0187-2.
   PubMed Web of Science ®Google Scholar
• Gloston, G. F., S. H. Yoo, and Z. J. Chen. 2017. Clock-enhancing small molecules and potential applications in chronic diseases and aging. Frontiers in Neurology 8:100. doi: 10.3389/fneur.2017.00100.
   PubMed Web of Science ®Google Scholar
• Goan, Y. G., W. T. Wu, C. I. Liu, C. A. Neoh, and Y. J. Wu. 2019. Involvement of mitochondrial dysfunction, endoplasmic reticulum stress, and the PI3K/AKT/mTOR pathway in nobiletin-induced apoptosis of human bladder cancer cells. Molecules 24 (16):2881. doi: 10.3390/molecules2416
   PubMed Web of Science ®Google Scholar
• Goh, J. X. H., L. T. Tan, J. K. Goh, K. G. Chan, P. Pusparajah, L. H. Lee, and B. H. Goh. 2019. Nobiletin and derivatives: Functional compounds from citrus fruit peel for colon cancer chemoprevention. Cancers (Basel) 11 (6):867. doi: 10.3390/cancers11060867.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez, R. R., Y. Xu, S. Guo, A. Watters, W. Zhou, and S. J. Leibovich. 2010. Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation. Cellular Signalling 22 (9):1350–62. doi: 10.1016/j.cellsig.2010.05.003.
   PubMed Web of Science ®Google Scholar
• Gottesman, M. M., I. Pastan, and S. V. Ambudkar. 1996. P-glycoprotein and multidrug resistance. Current Opinion in Genetics & Development 6 (5):610–7. doi: 10.1016/S0959-437X(96)80091-8.
   PubMed Web of Science ®Google Scholar
• Guney Eskiler, G., A. O. Deveci, C. Bilir, and S. Kaleli. 2019. Synergistic effects of nobiletin and sorafenib combination on metastatic prostate cancer cells. Nutrition and Cancer 71 (8):1299–312. doi: 10.1080/01635581.2019.1601237.
   PubMed Web of Science ®Google Scholar
• Guo, J. Y., B. Xia, and E. White. 2013. Autophagy-mediated tumor promotion. Cell 155 (6):1216–9. doi: 10.1016/j.cell.2013.11.019.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100 (1):57–70. doi: 10.1016/S0092-8674(00)81683-9.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of Cancer: The Next Generation. Cell 144 (5):646–74. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Hanske, L., G. Loh, S. Sczesny, M. Blaut, and A. Braune. 2009. The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. The Journal of Nutrition 139 (6):1095–102. doi: 10.3945/jn.108.102814.
   PubMed Web of Science ®Google Scholar
• Hernandez, P. A., R. J. Gorlin, J. N. Lukens, S. Taniuchi, J. Bohinjec, F. Francois, M. E. Klotman, and G. A. Diaz. 2003. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nature Genetics 34 (1):70–4. doi: 10.1038/ng1149.
   PubMed Web of Science ®Google Scholar
• He, Z., B. Li, G. O. Rankin, Y. Rojanasakul, and Y. C. Chen. 2015. Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells. Oncology Letters 9 (3):1444–50. doi: 10.3892/ol.2014.2818.
   PubMed Web of Science ®Google Scholar
• Honda, Y., F. Ushigome, N. Koyabu, S. Morimoto, Y. Shoyama, T. Uchiumi, M. Kuwano, H. Ohtani, and Y. Sawada. 2004. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. British Journal of Pharmacology 143 (7):856–64. doi: 10.1038/sj.bjp.0706008.
   PubMed Web of Science ®Google Scholar
• Hsiao, P. C., W. J. Lee, S. F. Yang, P. Tan, H. Y. Chen, L. M. Lee, J. L. Chang, G. M. Lai, J. M. Chow, and M. H. Chien. 2014. Nobiletin suppresses the proliferation and induces apoptosis involving MAPKs and caspase-8/-9/-3 signals in human acute myeloid leukemia cells. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35 (12):11903–11. doi: 10.1007/s13277-014-2457-0.
   PubMedGoogle Scholar
• Huang, H., L. F. Li, W. M. Shi, H. Liu, J. Q. Yang, X. L. Yuan, and L. H. Wu. 2016. The multifunctional effects of nobiletin and its metabolites in vivo and in vitro. Evidence-Based Complementary and Alternative Medicine : eCAM 2016:2918796. doi: 10.1155/2016/2918796.
   PubMed Web of Science ®Google Scholar
• Ikegawa, T., F. Ushigome, N. Koyabu, S. Morimoto, Y. Shoyama, M. Naito, T. Tsuruo, H. Ohtani, and Y. Sawada. 2000. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Letters 160 (1):21–8. doi: 10.1016/S0304-3835(00)00549-8.
   PubMed Web of Science ®Google Scholar
• Inami, Y., S. Waguri, A. Sakamoto, T. Kouno, K. Nakada, O. Hino, S. Watanabe, J. Ando, M. Iwadate, M. Yamamoto, et al. 2011. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. The Journal of Cell Biology 193 (2):275–84.,. doi: 10.1083/jcb.201102031.
   PubMed Web of Science ®Google Scholar
• Ishii, K., S. Tanaka, K. Kagami, K. Henmi, H. Toyoda, T. Kaise, and T. Hirano. 2010. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. Cancer Investigation 28 (3):220–9. doi: 10.3109/07357900902744486.
   PubMed Web of Science ®Google Scholar
• Itoh, N., C. Iwata, and H. Toda. 2016. Molecular cloning and characterization of a flavonoid-O-methyltransferase with broad substrate specificity and regioselectivity from Citrus depressa. BMC Plant Biology 16 (1):180. doi: 10.1186/s12870-016-0870-9.
   PubMedGoogle Scholar
• Jeong, W. S., and A. N. T. Kong. 2004. Biological properties of monomeric and polymeric catechins: Green tea catechins and procyanidins. Pharmaceutical Biology 42 (sup1):84–93. doi: 10.3109/13880200490893500.
   Google Scholar
• Jiang, H., H. Chen, C. Jin, J. Mo, and H. Wang. 2020. Nobiletin flavone inhibits the growth and metastasis of human pancreatic cancer cells via induction of autophagy, G0/G1 cell cycle arrest and inhibition of NF-kB signalling pathway. Journal of Balkan Union of Oncology 25:1070–5. PMID: 32521908.
   PubMed Web of Science ®Google Scholar
• Jiang, Y. P., H. Guo, and X. B. Wang. 2018. Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3/TAX ovarian cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 103:29–37. doi: 10.1016/j.biopha.2018.03.126.
   PubMed Web of Science ®Google Scholar
• Jordan, S., M. Murty, and K. Pilon. 2004. Products containing bitter orange or synephrine: Suspected cardiovascular adverse reactions. CMAJ: Canadian Medical Association Journal = Journal de L’Association Medicale Canadienne 171 (8):993–4. PMID: 15497209.
   PubMedGoogle Scholar
• Kandaswami, C., E. Perkins, D. S. Soloniuk, G. Drzewiecki, and E. Middleton. Jr. 1991. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Letters 56 (2):147–52. doi: 10.1016/0304-3835(91)90089-Z.
   PubMed Web of Science ®Google Scholar
• Kar, S., S. Palit, W. B. Ball, and P. K. Das. 2012. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis: An International Journal on Programmed Cell Death 17 (7):735–47. doi: 10.1007/s10495-012-0715-4.
   PubMed Web of Science ®Google Scholar
• Kaur, V., M. Kumar, A. Kumar, K. Kaur, V. S. Dhillon, and S. Kaur. 2018. Pharmacotherapeutic potential of phytochemicals: Implications in cancer chemoprevention and future perspectives. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 97:564–86. doi: 10.1016/j.biopha.2017.10.124.
   PubMed Web of Science ®Google Scholar
• Kawaii, S., Y. Tomono, E. Katase, K. Ogawa, and M. Yano. 1999. Antiproliferative activity of flavonoids on several cancer cell lines. Bioscience, Biotechnology, and Biochemistry 63 (5):896–9. doi: 10.1271/bbb.63.896.
   PubMed Web of Science ®Google Scholar
• Kesharwani, S. S., P. Mallya, V. A. Kumar, V. Jain, S. Sharma, and S. Dey. 2020. Nobiletin as a molecule for formulation development: An overview of advanced formulation and nanotechnology-based strategies of nobiletin. AAPS PharmSciTech 21 (6):226. doi: 10.1208/s12249-020-01767-0.
   PubMed Web of Science ®Google Scholar
• Kim, H., J. Y. Moon, A. Mosaddik, and S. K. Cho. 2010. Induction of apoptosis in human cervical carcinoma HeLa cells by polymethoxylated flavone-rich Citrus grandis Osbeck (Dangyuja) leaf extract. Food and Chemical Toxicology 48 (8–9):2435–42. doi: 10.1016/j.fct.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Kim, M. O., D. O. Moon, M. S. Heo, J. D. Lee, J. H. Jung, S. K. Kim, Y. H. Choi, and G. Y. Kim. 2008. Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis . Cancer Letters 271 (1):25–33. doi: 10.1016/j.canlet.2008.05.034.
   PubMed Web of Science ®Google Scholar
• Klein, G., E. Vellenga, M. W. Fraaije, W. A. Kamps, and E. de Bont. 2004. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Critical Reviews in Oncology/Hematology 50 (2):87–100. doi: 10.1016/j.critrevonc.2003.09.001.
   PubMed Web of Science ®Google Scholar
• Koga, N., M. Matsuo, C. Ohta, K. Haraguchi, M. Matsuoka, Y. Kato, T. Ishii, M. Yano, and H. Ohta. 2007. Comparative study on nobiletin metabolism with liver microsomes from rats, guinea pigs and hamsters and rat cytochrome P450. Biological & Pharmaceutical Bulletin 30 (12):2317–23. doi: 10.1248/bpb.30.2317.
   PubMed Web of Science ®Google Scholar
• Kola, I., and J. Landis. 2004. Can the pharmaceutical industry reduce attrition rates? Nature Reviews. Drug Discovery 3 (8):711–5. doi: 10.1038/nrd1470.
   PubMed Web of Science ®Google Scholar
• Krueger, A., S. Baumann, P. H. Krammer, and S. Kirchhoff. 2001. FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis. Molecular and Cellular Biology 21 (24):8247–54. doi: 10.1128/MCB.21.24.8247-8254.2001.
   PubMed Web of Science ®Google Scholar
• Le Roy, J., B. Huss, A. Creach, S. Hawkins, and G. Neutelings. 2016. Glycosylation is a major regulator of phenylpropanoid availability and biological activity in plants. Frontiers in Plant Science 7:735. doi: 10.3389/fpls.2016.00735.
   PubMed Web of Science ®Google Scholar
• Lechertier, T., and K. Hodivala-Dilke. 2012. Focal adhesion kinase and tumour angiogenesis. The Journal of Pathology 226 (2):404–12. doi: 10.1002/path.3018.
   PubMed Web of Science ®Google Scholar
• Lee, W. R., S. C. Shen, H. Y. Lin, W. C. Hou, L. L. Yang, and Y. C. Chen. 2002. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochemical Pharmacology 63 (2):225–36. doi: 10.1016/S0006-2952(01)00876-0.
   PubMed Web of Science ®Google Scholar
• Lellupitiyage Don, S. S., K. L. Robertson, H. H. Lin, C. Labriola, M. E. Harrington, S. R. Taylor, and M. E. Farkas. 2020. Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner. PLoS One 15 (7):e0236315. doi: 10.1371/journal.pone.0236315.
   PubMed Web of Science ®Google Scholar
• Lee, Y. C., T. H. Cheng, J. S. Lee, J. H. Chen, Y. C. Liao, Y. Fong, C. H. Wu, and Y. W. Shih. 2011. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Molecular and Cellular Biochemistry 347 (1–2):103–15. doi: 10.1007/s11010-010-0618-z.
   PubMed Web of Science ®Google Scholar
• Li, B., Y. Yang, E. J. Ning, Y. M. Peng, and J. J. Zhang. 2019. Mechanisms of poor oral bioavailability of flavonoid Morin in rats: From physicochemical to biopharmaceutical evaluations. European Journal of Pharmaceutical Sciences 128:290–8. doi: 10.1016/j.ejps.2018.12.011.
   PubMed Web of Science ®Google Scholar
• Li, X., C. Zhang, S. Guo, P. Rajaram, M. Lee, G. Chen, R. Fong, A. Gonzalez, Q. Zhang, S. Zheng, et al. 2018. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents. European Journal of Medicinal Chemistry 157:978–93. doi: 10.1016/j.ejmech.2018.08.047.
   PubMed Web of Science ®Google Scholar
• Lien, M., M. J. Wang, R. J. Chen, H. C. Chiu, J. L. Wu, M. Y. Shen, D. S. Chou, J. R. Sheu, K. H. Lin, and W. J. Lu. 2016. Nobiletin, a polymethoxylated flavone, inhibits glioma cell growth and migration via arresting cell cycle and suppressing MAPK and Akt pathways. Phytotherapy Research: PTR 30 (2):214–21. doi: 10.1002/ptr.5517.
   PubMed Web of Science ®Google Scholar
• Lin, C. X., C. W. Tu, Y. K. Ma, P. C. Ye, X. Shao, Z. A. Yang, and Y. M. Fang. 2020. Nobiletin inhibits cell growth through restraining aerobic glycolysis via PKA-CREB pathway in oral squamous cell carcinoma. Food Science & Nutrition 8 (7):3515–24. doi: 10.1002/fsn3.1634.
   PubMed Web of Science ®Google Scholar
• Lin, Y. G., A. B. Kunnumakkara, A. Nair, W. M. Merritt, L. Y. Han, G. N. Armaiz-Pena, A. A. Kamat, W. A. Spannuth, D. M. Gershenson, S. K. Lutgendorf, et al. 2007. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappa B pathway. Clinical Cancer Research 13 (11):3423–30. doi: 10.1158/1078-0432.CCR-06-3072.
   PubMed Web of Science ®Google Scholar
• Liu, F., S. Zhang, M. Yin, L. Guo, M. Xu, and Y. Wang. 2018a. Nobiletin inhibits hypoxia-induced epithelial-mesenchymal transition in renal cell carcinoma cells. Journal of Cellular Biochemistry 120 (2):2039–46. doi: 10.1002/jcb.27511.
   PubMed Web of Science ®Google Scholar
• Liu, H., and Z. Dong. 2021. Cancer etiology and prevention: "1 + X" principle. Cancer Research 81 (21):5377–95. doi: 10.1158/0008-5472.CAN-21-1862.
   PubMed Web of Science ®Google Scholar
• Liu, J., S. Wang, S. Tian, Y. He, H. Lou, Z. Yang, Y. Kong, and X. Cao. 2018b. Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-kappaB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells. Food and Nutrition Research 62:1323–1332. doi: 10.29219/fnr.v62.1323.
   Web of Science ®Google Scholar
• Luo, G., X. Guan, and L. Zhou. 2008. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biology & Therapy 7 (6):966–73. doi: 10.4161/cbt.7.6.5967.
   PubMed Web of Science ®Google Scholar
• Ma, W., S. Feng, X. Yao, Z. Yuan, L. Liu, and Y. Xie. 2015. Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells. Scientific Reports 5:18789. doi: 10.1038/srep18789.
   PubMed Web of Science ®Google Scholar
• Ma, X., S. Jin, Y. Zhang, L. Wan, Y. Zhao, and L. Zhou. 2014. Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo. Phytotherapy Research 28 (4):560–7. doi: 10.1002/ptr.5024.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, K., and Y. Ohizumi. 2021. Beneficial effects of citrus-derived polymethoxylated flavones for central nervous system disorders. Nutrients 13 (1):145. doi: 10.3390/nu13010
   PubMed Web of Science ®Google Scholar
• McDougall, S. R., A. R. A. Anderson, and M. A. J. Chaplain. 2006. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies. Journal of Theoretical Biology 241 (3):564–89. doi: 10.1016/j.jtbi.2005.12.022.
   PubMed Web of Science ®Google Scholar
• Meijer, J., and P. Codogno. 2009. Autophagy: Regulation and role in disease. Critical Reviews in Clinical Laboratory Sciences 46 (4):210–40. doi: 10.1080/10408360903044068.
   PubMed Web of Science ®Google Scholar
• Minagawa, A., Y. Otani, T. Kubota, N. Wada, T. Furukawa, K. Kumai, K. Kameyama, Y. Okada, M. Fujii, M. Yano, et al. 2001. The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Japanese Journal of Cancer Research: GANN 92 (12):1322–8. doi: 10.1111/j.1349-7006.2001.tb02156.x.
   PubMedGoogle Scholar
• Mirochnik, Y., A. Kwiatek, and O. V. Volpert. 2008. Thrombospondin and apoptosis: Molecular mechanisms and use for design of complementation treatments. Current Drug Targets 9 (10):851–62. doi: 10.2174/138945008785909347.
   PubMed Web of Science ®Google Scholar
• Miura, T., M. Chiba, K. Kasai, H. Nozaka, T. Nakamura, T. Shoji, T. Kanda, Y. Ohtake, and T. Sato. 2008. Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3. Carcinogenesis 29 (3):585–93. doi: 10.1093/carcin/bgm198.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., Y. Yasui, H. Ohigashi, T. Tanaka, and A. Murakami. 2010. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chemico-Biological Interactions 183 (2):276–83. doi: 10.1016/j.cbi.2009.11.002.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., Y. Yasui, T. Tanaka, H. Ohigashi, and A. Murakami. 2008. Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis 29 (5):1057–63. doi: 10.1093/carcin/bgn080.
   PubMed Web of Science ®Google Scholar
• Miyata, Y., T. Sato, and A. Ito. 2005. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells. Biochemical and Biophysical Research Communications 336 (4):1081–6. doi: 10.1016/j.bbrc.2005.08.247.
   PubMed Web of Science ®Google Scholar
• Miyata, Y., T. Sato, K. Imada, A. Dobashi, M. Yano, and A. Ito. 2008. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochemical and Biophysical Research Communications 366 (1):168–73. doi: 10.1016/j.bbrc.2007.11.100.
   PubMed Web of Science ®Google Scholar
• Mohana-Kumaran, N., D. S. Hill, J. D. Allen, and N. K. Haass. 2014. Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy. Pigment Cell & Melanoma Research 27 (4):525–39. doi: 10.1111/pcmr.12242.
   PubMed Web of Science ®Google Scholar
• Montané, X., O. Kowalczyk, B. Reig-Vano, A. Bajek, K. Roszkowski, R. Tomczyk, W. Pawliszak, M. Giamberini, A. Mocek-Płóciniak, and B. Tylkowski. 2020. Current perspectives of the applications of polyphenols and flavonoids in cancer therapy. Molecules 25 (15):3342. doi: 10.3390/molecules2515
   PubMed Web of Science ®Google Scholar
• Moon, J. Y., and S. K. Cho. 2016. Nobiletin induces protective autophagy accompanied by ER-stress mediated apoptosis in human gastric cancer SNU-16 cells. Molecules 21 (7):914. doi: 10.3390/molecules21070
   PubMed Web of Science ®Google Scholar
• Moon, J. Y., L. V. Manh Hung, T. Unno, and S. K. Cho. 2018. Nobiletin enhances chemosensitivity to adriamycin through modulation of the Akt/GSK3beta/beta(-)Catenin/MYCN/MRP1 signaling pathway in a549 human non-small-cell lung cancer cells. Nutrients 10 (12):1829. doi: 10.3390/nu1012
   PubMed Web of Science ®Google Scholar
• Moon, J. Y., M. Cho, K. S. Ahn, and S. K. Cho. 2013. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells. Nutrition and Cancer 65 (2):286–95. doi: 10.1080/01635581.2013.756529.
   PubMed Web of Science ®Google Scholar
• Morley, K. L., P. J. Ferguson, and J. Koropatnick. 2007. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Letters 251 (1):168–78. doi: 10.1016/j.canlet.2006.11.016.
   PubMed Web of Science ®Google Scholar
• Murakami, A., Y. Nakamura, Y. Ohto, M. Yano, T. Koshiba, K. Koshimizu, H. Tokuda, H. Nishino, and H. Ohigashi. 2000. Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. BioFactors (Oxford, England) 12 (1-4):187–92. doi: 10.1002/biof.5520120130.
   PubMed Web of Science ®Google Scholar
• Nemoto, K., A. Ikeda, C. Yoshida, J. Kimura, J. Mori, H. Fujiwara, A. Yokosuka, Y. Mimaki, Y. Ohizumi, and M. Degawa. 2013. Characteristics of nobiletin-mediated alteration of gene expression in cultured cell lines. Biochemical and Biophysical Research Communications 431 (3):530–4. doi: 10.1016/j.bbrc.2013.01.024.
   PubMed Web of Science ®Google Scholar
• Newman, D. J., and G. M. Cragg. 2020. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products 83 (3):770–803. doi: 10.1021/acs.jnatprod.9b01285.
   PubMed Web of Science ®Google Scholar
• Nguyen, V. S., W. Li, Y. Li, and Q. A. Wang. 2017. Synthesis of citrus polymethoxyflavonoids and their antiproliferative activities on Hela cells. Medicinal Chemistry Research 26 (7):1585–92. doi: 10.1007/s00044-017-1871-4.
   Web of Science ®Google Scholar
• Nguyen-Ngo, C., C. Salomon, S. Quak, A. Lai, J. C. Willcox, and M. Lappas. 2020. Nobiletin exerts anti-diabetic and anti-inflammatory effects in an in vitro human model and in vivo murine model of gestational diabetes. Clinical Science (London, England : 1979) 134 (6):571–92. doi: 10.1042/CS20191099.
   PubMed Web of Science ®Google Scholar
• Nia, H. D. T., L. L. Munn, and R. K. Jain. 2020. Physical traits of cancer. Science 370 (6516):546. +, . doi: 10.1126/science.aaz0868.
   Web of Science ®Google Scholar
• Ohnishi, H., M. Asamoto, K. Tujimura, N. Hokaiwado, S. Takahashi, K. Ogawa, M. Kuribayashi, T. Ogiso, H. Okuyama, and T. Shirai. 2004. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Science 95 (12):936–42. doi: 10.1111/j.1349-7006.2004.tb03180.x.
   PubMed Web of Science ®Google Scholar
• Ohtani, H., T. Ikegawa, Y. Honda, N. Kohyama, S. Morimoto, Y. Shoyama, M. Juichi, M. Naito, T. Tsuruo, and Y. Sawada. 2007. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. Pharmaceutical Research 24 (10):1936–43. doi: 10.1007/s11095-007-9320-6.
   PubMed Web of Science ®Google Scholar
• Onoue, S., T. Nakamura, A. Uchida, K. Ogawa, K. Yuminoki, N. Hashimoto, A. Hiza, Y. Tsukaguchi, T. Asakawa, T. Kan, et al. 2013. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects. European Journal of Pharmaceutical Sciences : official Journal of the European Federation for Pharmaceutical Sciences 49 (4):453–60. doi: 10.1016/j.ejps.2013.05.014.
   PubMed Web of Science ®Google Scholar
• Osz, K., M. Ross, and J. Petrik. 2014. The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis. Reproductive Biology and Endocrinology: RB&E 12:21. doi: 10.1186/1477-7827-12-21.
   PubMed Web of Science ®Google Scholar
• Ouyang, Y., L. Li, and P. Ling. 2020. Nobiletin inhibits helicobacterium pylori infection-induced gastric carcinogenic signaling by blocking inflammation, apoptosis, and mitogen-activated protein kinase events in gastric epithelial-1 cells. Journal of Environmental Pathology, Toxicology and Oncology: official Organ of the International Society for Environmental Toxicology and Cancer 39 (1):77–88. doi: 10.1615/JEnvironPatholToxicolOncol.2020031272.
   PubMed Web of Science ®Google Scholar
• Park, S. I., A. N. Shah, J. Zhang, and G. E. Gallick. 2007. Regulation of angiogenesis and vascular permeability by Src family kinases: Opportunities for therapeutic treatment of solid tumors. Expert Opinion on Therapeutic Targets 11 (9):1207–17. doi: 10.1517/14728222.11.9.1207.
   PubMed Web of Science ®Google Scholar
• Pereira, C., M. Duarte, P. Silva, A. Bento da Silva, C. Duarte, A. Cifuentes, V. García-Cañas, M. Bronze, C. Albuquerque, and A. Serra. 2019. Polymethoxylated flavones target cancer stemness and improve the antiproliferative effect of 5-fluorouracil in a 3D cell model of colorectal cancer. Nutrients 11 (2):326. doi: 10.3390/nu11020
   PubMed Web of Science ®Google Scholar
• Pham, T. H., Y. L. Page, F. Percevault, F. Ferriere, G. Flouriot, and F. Pakdel. 2021. Apigenin, a partial antagonist of the estrogen receptor (ER), inhibits ER-positive breast cancer cell proliferation through Akt/FOXM1 signaling. International Journal of Molecular Sciences 22 (1):470. doi: 10.3390/ijms22010
   PubMed Web of Science ®Google Scholar
• Ponte, L. G. S., I. C. B. Pavan, M. C. S. Mancini, L. G. S. da Silva, A. P. Morelli, M. B. Severino, R. M. N. Bezerra, and F. M. Simabuco. 2021. The hallmarks of flavonoids in cancer. Molecules 26 (7):2029. doi: 10.3390/molecules2607
   PubMed Web of Science ®Google Scholar
• Qiu, P., P. Dong, H. Guan, S. Li, C. T. Ho, M. H. Pan, D. J. McClements, and H. Xiao. 2010. Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Molecular Nutrition & Food Research 54 Suppl 2:S244–S252. doi: 10.1002/mnfr.200900605.
   PubMed Web of Science ®Google Scholar
• Rahideh, S. T., M. Keramatipour, M. Nourbakhsh, F. Koohdani, M. Hoseini, and F. Shidfar. 2017a. The effects of nobiletin, hesperetin, and letrozole in a combination on the activity and expression of aromatase in breast cancer cells. Cellular and Molecular Biology (Noisy-le-Grand, France) 63 (2):9–13. doi: 10.14715/cmb/2017.63.2.2.
   PubMed Web of Science ®Google Scholar
• Rahideh, S. T., M. Keramatipour, M. Nourbakhsh, F. Koohdani, M. Hoseini, S. Talebi, and F. Shidfar. 2017b. Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line. Biochemistry and Cell Biology 95 (4):468–73. doi: 10.1139/bcb-2016-0206.
   PubMedGoogle Scholar
• Rampogu, S., S. Parate, S. Parameswaran, C. Park, A. Baek, M. Son, Y. Park, S. J. Park, and K. W. Lee. 2019. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies. Computational Biology and Chemistry 83 doi: 10.1016/j.compbiolchem.2019.107113.
   PubMed Web of Science ®Google Scholar
• Rao, S., L. Tortola, T. Perlot, G. Wirnsberger, M. Novatchkova, R. Nitsch, P. Sykacek, L. Frank, D. Schramek, V. Komnenovic, et al. 2014. A dual role for autophagy in a murine model of lung cancer. Nature Communications 5 (1):3056. doi: 10.1038/ncomms4056.
   PubMedGoogle Scholar
• Rooprai, H. K., A. Kandanearatchi, S. L. Maidment, M. Christidou, G. Trillo-Pazos, D. T. Dexter, G. J. Rucklidge, W. Widmer, and G. J. Pilkington. 2001. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathology and Applied Neurobiology 27 (1):29–39. doi: 10.1046/j.0305-1846.2000.00298.x.
   PubMed Web of Science ®Google Scholar
• Rozovski, U., D. M. Harris, P. Li, Z. M. Liu, P. Jain, A. Ferrajoli, J. A. Burger, P. Bose, P. A. Thompson, and N. Jain. 2017. Overexpression of CD36, driven by STAT3, mediates free fatty acid uptake in CLL cells. Blood 130:4301. doi: 10.1182/blood.V130.Suppl_1.4301.4301.
   Web of Science ®Google Scholar
• Rubicz, R., S. Zhao, C. April, J. L. Wright, S. Kolb, I. Coleman, D. W. Lin, P. S. Nelson, E. A. Ostrander, Z. Feng, et al. 2015. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort. The Prostate 75 (13):1354–62. doi: 10.1002/pros.23016.
   PubMed Web of Science ®Google Scholar
• Saito, T., D. Abe, and Y. Nogata. 2015. Polymethoxylated flavones potentiate the cytolytic activity of NK leukemia cell line KHYG-1 via enhanced expression of granzyme B. Biochemical and Biophysical Research Communications 456 (3):799–803. doi: 10.1016/j.bbrc.2014.12.027.
   PubMed Web of Science ®Google Scholar
• Saito, T., D. Abe, and Y. Nogata. 2020. Nobiletin and related polymethoxylated flavones bind to and inhibit the nuclear export factor Exportin-1 in NK leukemia cell line KHYG-1. Biochemical and Biophysical Research Communications 521 (2):457–62. doi: 10.1016/j.bbrc.2019.10.129.
   PubMed Web of Science ®Google Scholar
• Sato, T., L. Koike, Y. Miyata, M. Hirata, Y. Mimaki, Y. Sashida, M. Yano, and A. Ito. 2002. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Research 62 (4):1025–9.
   PubMed Web of Science ®Google Scholar
• Sato, T., M. Iwai, T. Sakai, H. Sato, M. Seiki, Y. Mori, and A. Ito. 1999. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. British Journal of Cancer 80 (8):1137–43. doi: 10.1038/sj.bjc.6690477.
   PubMed Web of Science ®Google Scholar
• Sekiguchi, H., K. Washida, and A. Murakami. 2008. Suppressive effects of selected food phytochemicals on CD74 expression in NCI-N87 gastric carcinoma cells. Journal of Clinical Biochemistry and Nutrition 43 (2):109–17. doi: 10.3164/jcbn.2008054.
   PubMed Web of Science ®Google Scholar
• Senga, S. S., and R. P. Grose. 2021. Hallmarks of cancer-the new testament. Open Biology 11 (1):200358. doi: 10.1098/rsob.
   PubMed Web of Science ®Google Scholar
• Shi, D., Y. C. Liao, Y. W. Shih, and L. Y. Tsai. 2013. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Phytomedicine : international Journal of Phytotherapy and Phytopharmacology 20 (8-9):743–52. doi: 10.1016/j.phymed.2013.02.004.
   PubMed Web of Science ®Google Scholar
• Shukla, S., G. T. Maclennan, D. J. Hartman, P. Fu, M. I. Resnick, and S. Gupta. 2007. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. International Journal of Cancer 121 (7):1424–32. doi: 10.1002/ijc.22862.
   PubMed Web of Science ®Google Scholar
• Sieg, J., C. R. Hauck, D. Ilic, C. K. Klingbeil, E. Schaefer, C. H. Damsky, and D. D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nature Cell Biology 2 (5):249–56. doi: 10.1038/35010517.
   PubMed Web of Science ®Google Scholar
• Silva, I., M. F. Estrada, C. V Pereira, A. B. da Silva, M. R. Bronze, P. M. Alves, C. M. M. Duarte, C. Brito, and A. T. Serra. 2018. Polymethoxylated flavones from orange peels inhibit cell proliferation in a 3D cell model of human colorectal cancer. Nutrition and Cancer 70 (2):257–66. doi: 10.1080/01635581.2018.1412473.
   PubMed Web of Science ®Google Scholar
• Silverstein, R. L., M. Baird, S. K. Lo, and L. M. Yesner. 1992. Sense and antisense CDNA transfection of CD36 (Glycoprotein-IV) in melanoma-cells-role of CD36 as a thrombospondin receptor. Journal of Biological Chemistry 267 (23):16607–12. doi: 10.1016/S0021-9258(18)42046-7.
   PubMed Web of Science ®Google Scholar
• Song, M., N. Charoensinphon, X. Wu, J. Zheng, Z. Gao, F. Xu, M. Wang, and H. Xiao. 2016. Inhibitory effects of metabolites of 5-demethylnobiletin on human nonsmall cell lung cancer cells. Journal of Agricultural and Food Chemistry 64 (24):4943–9. doi: 10.1021/acs.jafc.6b01367.
   PubMed Web of Science ®Google Scholar
• Sousa, P., M. Pojo, A. T. Pinto, V. Leite, A. T. Serra, and B. M. Cavaco. 2020. Nobiletin alone or in combination with cisplatin decreases the viability of anaplastic thyroid cancer cell lines. Nutrition and Cancer 72 (2):352–63. doi: 10.1080/01635581.2019.1634745.
   PubMed Web of Science ®Google Scholar
• Sp, N., D. Kang, Y. Joung, J. Park, W. Kim, H. Lee, K.-D. Song, Y.-M. Park, and Y. Yang. 2017. Nobiletin inhibits angiogenesis by regulating Src/FAK/STAT3-mediated signaling through PXN in ER(+) breast cancer cells. International Journal of Molecular Sciences 18 (5):935. doi: 10.3390/ijms18050935.
   PubMed Web of Science ®Google Scholar
• Sp, N., D. Y. Kang, D. H. Kim, J. H. Park, H. G. Lee, H. J. Kim, P. Darvin, Y. M. Park, and Y. M. Yang. 2018. Nobiletin inhibits CD36-dependent tumor angiogenesis. Nutrients 10 (6):772. doi: 10.3390/nu10060772.
   PubMed Web of Science ®Google Scholar
• Stoner, D. 2020. Food-based approach to cancer prevention. Food Frontiers 1 (1):6–8. doi: 10.1002/fft2.3.
   Google Scholar
• Sun, D. Q., H. Li, M. M. Cao, S. Y. He, L. Lei, J. Peng, and W. Q. Chen. 2020. Cancer burden in China: Trends, risk factors and prevention. Cancer Biology & Medicine 17 (4):879–95. doi: 10.20892/j.issn.2095-3941.2020.0387.
   PubMed Web of Science ®Google Scholar
• Sun, Y., Y. Han, M. Song, N. Charoensinphon, J. Zheng, P. Qiu, X. Wu, and H. Xiao. 2019. Inhibitory effects of nobiletin and its major metabolites on lung tumorigenesis. Food & Function 10 (11):7444–52. doi: 10.1039/c9fo01966a.
   PubMed Web of Science ®Google Scholar
• Sung, H., J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 71 (3):209–49. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Surichan, S., R. R. Arroo, K. Ruparelia, A. M. Tsatsakis, and V. P. Androutsopoulos. 2018. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 113:228–35. doi: 10.1016/j.fct.2018.01.047.
   PubMed Web of Science ®Google Scholar
• Surichan, S., V. P. Androutsopoulos, S. Sifakis, E. Koutala, A. Tsatsakis, R. R. Arroo, and M. R. Boarder. 2012. Bioactivation of the citrus flavonoid nobiletin by CYP1 enzymes in MCF7 breast adenocarcinoma cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 50 (9):3320–8. doi: 10.1016/j.fct.2012.06.030.
   PubMed Web of Science ®Google Scholar
• Takanaga, H., A. Ohnishi, S. Yamada, H. Matsuo, S. Morimoto, Y. Shoyama, H. Ohtani, and Y. Sawada. 2000. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. The Journal of Pharmacology and Experimental Therapeutics 293 (1):230–6. doi: 10.1104/pp.122.4.1129.
   PubMed Web of Science ®Google Scholar
• Tang, M., K. Ogawa, M. Asamoto, N. Hokaiwado, A. Seeni, S. Suzuki, S. Takahashi, T. Tanaka, K. Ichikawa, and T. Shirai. 2007. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Science 98 (4):471–7. doi: 10.1111/j.1349-7006.2007.00417.x.
   PubMed Web of Science ®Google Scholar
• Tsai, W.-C., T.-Y. Yu, L.-P. Lin, M.-S. Lin, Y.-C. Wu, C.-H. Liao, and J.-H S. Pang. 2017. Platelet rich plasma releasate promotes proliferation of skeletal muscle cells in association with upregulation of PCNA, cyclins and cyclin dependent kinases. Platelets 28 (5):491–7. doi: 10.1080/09537104.2016.1227061.
   PubMed Web of Science ®Google Scholar
• Uesato, S., H. Yamashita, R. Maeda, Y. Hirata, M. Yamamoto, S. Matsue, Y. Nagaoka, M. Shibano, M. Taniguchi, K. Baba, et al. 2014. Synergistic antitumor effect of a combination of paclitaxel and carboplatin with nobiletin from Citrus depressa on non-small-cell lung cancer cell lines. Planta Medica 80 (6):452–7.,. doi: 10.1055/s-0034-1368321.
   PubMed Web of Science ®Google Scholar
• Van Rymenant, E., B. Salden, S. Voorspoels, G. Jacobs, B. Noten, J. Pitart, S. Possemiers, G. Smagghe, C. Grootaert, and J. Van Camp. 2018. A critical evaluation of in vitro hesperidin 2S bioavailability in a model combining luminal (microbial) digestion and Caco-2 cell absorption in comparison to a randomized controlled human trial. Molecular Nutrition & Food Research 62 (8):1700881. doi: 10.1002/mnfr.20
   Web of Science ®Google Scholar
• Wang, S. W., T. Lan, H. Sheng, F. Zheng, M. K. Lei, L. X. Wang, H. F. Chen, C. Y. Xu, and F. Zhang. 2021a. Nobiletin alleviates non-alcoholic steatohepatitis in MCD-induced mice by regulating macrophage polarization. Frontiers in Physiology 12:687744. doi: 10.3389/fphys.2021.687744.
   PubMed Web of Science ®Google Scholar
• Wang, S., Y. G. Wang, Y. L. Luo, Y. Liu, and W. W. Su. 2013. In vitro and in vivo evaluation of naringin sustained-release pellets compared with immediate-release tablets. Journal of Drug Delivery Science and Technology 23 (5):459–64. doi: 10.1016/S1773-2247(13)50066-9.
   Web of Science ®Google Scholar
• Wang, S., Y. Hu, Y. Yan, Z. Cheng, and T. Liu. 2018a. Sotetsuflavone inhibits proliferation and induces apoptosis of A549 cells through ROS-mediated mitochondrial-dependent pathway. BMC Complementary and Alternative Medicine 18 (1):235. doi: 10.1186/s12906-018-2300-z.
   PubMedGoogle Scholar
• Wang, T. Y., Q. Li, and K. S. Bi. 2018b. Bioactive flavonoids in medicinal plants: Structure, activity and biological fate. Asian Journal of Pharmaceutical Sciences 13 (1):12–23. doi: 10.1016/j.ajps.2017.08.004.
   PubMed Web of Science ®Google Scholar
• Wang, Y. J., M. H. Pan, A. L. Cheng, L. I. Lin, Y. S. Ho, C. Y. Hsieh, and J. K. Lin. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedical Analysis 15 (12):1867–76. doi: 10.1016/S0731-7085(96)02024-9.
   PubMed Web of Science ®Google Scholar
• Wang, Y. W., S. C. Wang, C. K. Firempong, H. Y. Zhang, M. M. Wang, Y. Zhang, Y. Zhu, J. N. Yu, and X. M. Xu. 2017. Enhanced Solubility and Bioavailability of Naringenin via Liposomal Nanoformulation: Preparation and In Vitro and In Vivo Evaluations. AAPS PharmSciTech 18 (3):586–94. doi: 10.1208/s12249-016-0537-8.
   PubMed Web of Science ®Google Scholar
• Wang, Y., J. Zhong, J. Bai, R. Tong, F. An, P. Jiao, L. He, D. Zeng, E. Long, J. Yan, et al. 2018b. The application of natural products in cancer therapy by targeting apoptosis pathways. Current Drug Metabolism 19 (9):739–49. doi: 10.2174/1389200219666180511154722.
   PubMed Web of Science ®Google Scholar
• Wang, Y., X. J. Liu, J. B. Chen, J. P. Cao, X. Li, and C. D. Sun. 2021b. Citrus flavonoids and their antioxidant evaluation. Critical Reviews in Food Science and Nutrition 1–22. doi: 10.1080/10408398.2020.1870035.
   Web of Science ®Google Scholar
• Webb, D. J., K. Donais, L. A. Whitmore, S. M. Thomas, C. E. Turner, J. T. Parsons, and A. F. Horwitz. 2004. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nature Cell Biology 6 (2):154–61. doi: 10.1038/ncb1094.
   PubMed Web of Science ®Google Scholar
• Wei, D., G. Zhang, Z. Zhu, Y. Zheng, F. Yan, C. Pan, Z. Wang, X. Li, F. Wang, P. Meng, et al. 2019. Nobiletin inhibits cell viability via the SRC/AKT/STAT3/YY1AP1 pathway in human renal carcinoma cells. Frontiers in Pharmacology 10:690. doi: 10.3389/fphar.2019.00690.
   PubMed Web of Science ®Google Scholar
• Wei, X., and X. Shao. 2018. Nobiletin alleviates endometriosis via down-regulating NF-kappa B activity in endometriosis mouse model. Bioscience Reports 38 (3):BSR20180470. doi: 10.1042/BSR20180470.
   PubMedGoogle Scholar
• Weng, C.-J., and G.-C. Yen. 2012. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treatment Reviews 38 (1):76–87. doi: 10.1016/j.ctrv.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Wu, X., M. Song, M. Wang, J. Zheng, Z. Gao, F. Xu, G. Zhang, and H. Xiao. 2015. Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis. Molecular Nutrition & Food Research 59 (12):2383–94. doi: 10.1002/mnfr.201500378.
   PubMed Web of Science ®Google Scholar
• Wu, X., M. Song, P. Qiu, F. Li, M. Wang, J. Zheng, Q. Wang, F. Xu, and H. Xiao. 2018. A metabolite of nobiletin, 4’-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis. Food & Function 9 (1):87–95. doi: 10.1039/c7fo01155e.
   PubMed Web of Science ®Google Scholar
• Wu, X., M. Song, P. Qiu, K. Rakariyatham, F. Li, Z. Gao, X. Cai, M. Wang, F. Xu, J. Zheng, et al. 2017b. Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis. Carcinogenesis 38 (4):455–64. doi: 10.1093/carcin/bgx018.
   PubMed Web of Science ®Google Scholar
• Wu, X., M. Song, Z. Gao, Y. Sun, M. Wang, F. Li, J. Zheng, and H. Xiao. 2017a. Nobiletin and its colonic metabolites suppress colitis-associated colon carcinogenesis by down-regulating iNOS, inducing antioxidative enzymes and arresting cell cycle progression. The Journal of Nutritional Biochemistry 42:17–25. doi: 10.1016/j.jnutbio.2016.12.020.
   PubMed Web of Science ®Google Scholar
• Yang, C. S. 2020. Studies on the health effects of food: Approaches and pitfalls. Food Frontiers 1 (4):358–9. doi: 10.1002/fft2.41.
   Google Scholar
• Yang, G., C. C. Lin, Y. Yang, L. Yuan, P. Wang, X. Wen, M. H. Pan, H. Zhao, C. T. Ho, and S. Li. 2019. Nobiletin prevents trimethylamine oxide-induced vascular inflammation via inhibition of the NF-κB/MAPK pathways . Journal of Agricultural and Food Chemistry 67 (22):6169–76. doi: 10.1021/acs.jafc.9b01270.
   PubMed Web of Science ®Google Scholar
• Yang, X., S. Li, J. Zhong, W. Zhang, X. Hua, B. Li, and H. Sun. 2017. CD151 mediates netrin-1-induced angiogenesis through the Src-FAK-Paxillin pathway. Journal of Cellular and Molecular Medicine 21 (1):72–80. doi: 10.1111/jcmm.12939.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Yang, L. Wang, Q. Jin, and M. Pan. 2020. Nobiletin selectively inhibits oral cancer cell growth by promoting apoptosis and DNA damage in vitro. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology 130 (4):419–477. doi: 10.1016/j.oooo.2020.06.020.
   PubMed Web of Science ®Google Scholar
• Yen, H., C. Y. Lin, C. H. Chuang, H. K. Chin, M. J. Wu, and P. Y. Chen. 2020. Nobiletin promotes megakaryocytic differentiation through the MAPK/ERK-dependent EGR1 expression and exerts anti-leukemic effects in human chronic myeloid leukemia (CML) K562 cells. Cells 9 (4):877. doi: 10.3390/cells9040877.
   PubMed Web of Science ®Google Scholar
• Yoshimizu, N., Y. Otani, Y. Saikawa, T. Kubota, M. Yoshida, T. Furukawa, K. Kumai, K. Kameyama, M. Fujii, M. Yano, et al. 2004. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: Antiproliferative effects, induction of apoptosis and cell cycle deregulation. Alimentary Pharmacology & Therapeutics 20 (Suppl 1):95–101. doi: 10.1111/j.1365-2036.2004.02082.x.
   PubMedGoogle Scholar
• Yoshizaki, N., R. Hashizume, and H. Masaki. 2017. A polymethoxyflavone mixture extracted from orange peels, mainly containing nobiletin, 3,3’,4’,5,6,7,8-heptamethoxyflavone and tangeretin, suppresses melanogenesis through the acidification of cell organelles, including melanosomes. Journal of Dermatological Science 88 (1):78–84. doi: 10.1016/j.jdermsci.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Yousef, E. H., M. E. El-Mesery, M. R. Habeeb, and L. A. Eissa. 2020. Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 42 (4):1010428320914475. doi: 10.1177/1010428320914475.
   Google Scholar
• Zhang, B. F., H. Jiang, J. Chen, X. Guo, Y. Li, Q. Hu, and S. Yang. 2019. Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway. International Immunopharmacology 73:98–107. doi: 10.1016/j.intimp.2019.04.060.
   PubMed Web of Science ®Google Scholar
• Zhang, C., Y. Lu, L. Tao, X. Tao, X. Su, and D. Wei. 2007. Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. Journal of Enzyme Inhibition and Medicinal Chemistry. 22 (1):91–8. doi: 10.1080/14756360600988989.
   PubMed Web of Science ®Google Scholar
• Zhang, H., P. Lv, Z. Xiao, E. A. Jothi, and J. Yang. 2020a. Nobiletin attenuates cell proliferation by modulating the activating protein-1 signaling pathway in 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis. Journal of Environmental Pathology, Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 39 (1):13–21. doi: 10.1615/JEnvironPatholToxicolOncol.2019031445.
   PubMed Web of Science ®Google Scholar
• Zhang, M., R. Zhang, J. Liu, H. Wang, Z. Wang, J. Liu, Y. Shan, and H. Yu. 2020b. The effects of 5,6,7,8,3’,4’-hexamethoxyflavone on apoptosis of cultured human choriocarcinoma trophoblast cells. Molecules 25 (4):946. doi: 10.3390/molecules25040946.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., Y. Feng, and D. Kennedy. 2017a. Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this? Cellular and Molecular Life Sciences: CMLS 74 (5):777–801. doi: 10.1007/s00018-016-2362-3.
   PubMed Web of Science ®Google Scholar
• Zhang, R., J. Chen, L. Mao, Y. Guo, Y. Hao, Y. Deng, X. Han, Q. Li, W. Liao, and M. Yuan. 2020c. Nobiletin triggers reactive oxygen species-mediated pyroptosis through regulating autophagy in ovarian cancer cells. Journal of Agricultural and Food Chemistry 68 (5):1326–36. doi: 10.1021/acs.jafc.9b07908.
   PubMed Web of Science ®Google Scholar
• Zhang, X., K. Zheng, C. Li, Y. Zhao, H. Li, X. Liu, Y. Long, and J. Yao. 2017b. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Oncology Reports 37 (5):2847–56. doi: 10.3892/or.2017.5522.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., F. X. Wang, K. K. Jia, and L. D. Kong. 2018. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Frontiers in Pharmacology 9:1253. doi: 10.3389/fphar.2018.01253.
   PubMed Web of Science ®Google Scholar
• Zheng, G. D., P. J. Hu, Y. X. Chao, Y. Zhou, X. J. Yang, B. Z. Chen, X. Y. Yu, and Y. Cai. 2019. Nobiletin induces growth inhibition and apoptosis in human nasopharyngeal carcinoma C666-1 cells through regulating PARP-2/SIRT1/AMPK signaling pathway. Food Science & Nutrition 7 (3):1104–12. doi: 10.1002/fsn3.953.
   PubMed Web of Science ®Google Scholar
• Zheng, Q., Y. Hirose, N. Yoshimi, A. Murakami, K. Koshimizu, H. Ohigashi, K. Sakata, Y. Matsumoto, Y. Sayama, and H. Mori. 2002. Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells. Journal of Cancer Research and Clinical Oncology 128 (10):539–46. doi: 10.1007/s00432-002-0373-y.
   PubMed Web of Science ®Google Scholar
• Zhu, L., K. Z. Sanidad, E. Sukamtoh, and G. D. Zhang. 2017. Potential roles of chemical degradation in the biological activities of curcumin. Food & Function 8 (3):907–14. doi: 10.1039/c6fo01770c.
   PubMed Web of Science ®Google Scholar
• Zhuang, J., J. Yin, C. Xu, Y. Mu, and S. Lv. 2018. 20(S)-Ginsenoside Rh2 induce the apoptosis and autophagy in U937 and K562 cells. Nutrients 10 (3):328. doi: 10.3390/nu10030328.
   PubMed Web of Science ®Google Scholar